Inventor · disambiguated record
Bernard Thomas Golding
Also filed as: GOLDING BERNARD · GOLDING BERNARD T · GOLDING BERNARD THOMAS
30 granted patents·33 pending applications·414 citations·filing 1996–2024
97Inventor score
Files withSHIRE LLC17FRANKLIN RICHARD8ASTEX THERAPEUTICS LTD7UNIV NEWCASTLE VENTURES LTD7CANCER REC TECH LTD4
Top patents by PatentIndex Score
63 records- 0197US5756510ABenzamide analogs useful as PARP (ADP-ribosyltransferase, ADPRT) DNA repair enzyme inhibitorsUNIV NEWCASTLE VENTURES LTD·Filed 1996·Granted May 26, 1998·98 cites·10 claims
- 0295US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0394US6310082B1Benzimidazole compoundsUNIV NEWCASTLE VENTURES LTD·Filed 2000·Granted Oct 30, 2001·43 cites·21 claims
- 0492US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0592US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0690US7402607B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2005·Granted Jul 22, 2008·16 cites·13 claims
- 0788US10414726B2Therapeutic agentsCANCER RESEARCH TECH LTD·Filed 2017·Granted Sep 17, 2019·6 cites·19 claims
- 0888US6100283ABenzimidazole compoundsUNIV NEWCASTLE VENTURES LTD·Filed 1998·Granted Aug 8, 2000·49 cites·9 claims
- 0987US9358222B2Therapeutic agentsCANCER REC TECH LTD·Filed 2013·Granted Jun 7, 2016·9 cites·12 claims
- 1087US6156739AQuinazolinone compoundsUNIV NEWCASTLE VENTURES LTD·Filed 1999·Granted Dec 5, 2000·46 cites·19 claims
- 1186US6015827ABenzoxazole-4-carboxamides and their use in inhibiting poly (adp-ribose) polymerase activity and improving cytotoxic effectiveness of cytotoxic drugs or radiotherapyUNIV NEWCASTLE VENTURES LTD·Filed 1998·Granted Jan 18, 2000·28 cites·9 claims
- 1285US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 1383US8618158B2Therapeutic agentsGOLDING BERNARD THOMAS·Filed 2009·Granted Dec 31, 2013·10 cites·19 claims
- 1483US7910597B2Substituted quinazolinesSHIRE LLC·Filed 2007·Granted Mar 22, 2011·3 cites·5 claims
- 1582US8258175B2Isoindolin-1-one derivativesWILLEMS HENDRIKA MARIA GERARDA·Filed 2005·Granted Sep 4, 2012·10 cites·9 claims
- 1682US7674823B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2007·Granted Mar 9, 2010·3 cites·7 claims
- 1782US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1880US6303618B1Cyclin dependent kinase inhibiting purine derivativesCANCER RES CAMPAIGN TECH·Filed 2000·Granted Oct 16, 2001·17 cites·15 claims
- 1977US7696203B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Apr 13, 2010·4 cites·9 claims
- 2073US10344017B2Pyrrolcarboxamide derivatives for the inhibition of ERK5CANCER RESEARCH TECH LTD·Filed 2015·Granted Jul 9, 2019·2 cites·20 claims
- 2171US7226918B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Jun 5, 2007·4 cites·9 claims
- 2270US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 2370US7105518B2Thiopyrane-4-ones as DNA protein kinase inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Sep 12, 2006·5 cites·8 claims
- 2467US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2565US2024294488A1Isotopologes, salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2663US6316455B1Method of improving the effectiveness of a cytotoxic drug or radiotherapy using a quinazolinone compoundUNIV NEWCASTLE VENTURES LTD·Filed 1999·Granted Nov 13, 2001·14 cites·8 claims
- 2761US6677345B1Cyclin dependent kinase inhibitorsCANCER RES CAMPAIGN TECH·Filed 2000·Granted Jan 13, 2004·1 cites·28 claims
- 2860US8304420B2Substituted quinazolines for reducing platelet countFRANKLIN RICHARD·Filed 2007·Granted Nov 6, 2012·1 cites·10 claims
- 2958US7732483B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2008·Granted Jun 8, 2010·0 cites·11 claims
- 3058US2009192095A1Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effectsSHIRE LLC·Filed 2009·Application pending·0 cites
- 3158US2009186832A1Amino acid peptide pro-drugs of phenolic analgesics and uses thereofSHIRE LLC·Filed 2009·Application pending·0 cites
- 3254US2011071171A12h- pyrimido [2, 1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agentsSHIRE LLC·Filed 2009·Application pending·0 cites
- 3354US2011130405A1Substituted quinazolines as blood platelet lowering agentsSHIRE LLC·Filed 2009·Application pending·0 cites
- 3452US2011130386A1Dna-pk inhibitorsFRIGERIO MARK·Filed 2009·Application pending·0 cites
- 3552US2016355478A1Therapeutic agentsCANCER RES TECH LTD·Filed 2016·Application pending·0 cites
- 3651US2011071173A1Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseasesSHIRE LLC·Filed 2009·Application pending·0 cites
- 3751US2011071172A1Substituted quinazolines as blood platelet lowering agentsSHIRE LLC·Filed 2009·Application pending·0 cites
- 3851US2011071174A1Substituted quinazolinesSHIRE LLC·Filed 2009·Application pending·0 cites
- 3950US2011065714A1Substituted quinazolinesSHIRE LLC·Filed 2009·Application pending·0 cites
- 4048US2011065735A1Substituted quinazolinesSHIRE LLC·Filed 2009·Application pending·0 cites
- 4147US6297250B1Pyrimidopyrimidine compoundsUNIV NEWCASTLE VENTURES LTD·Filed 1999·Granted Oct 2, 2001·3 cites·18 claims
- 4247US5985913ATetracyclic compounds for enhancing biosynthesis of erythropoietin, compositions containing same, and methods of use thereofOSI PHARM INC·Filed 1998·Granted Nov 16, 1999·12 cites·28 claims
- 4347US2011152298A1Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agentsSHIRE LLC·Filed 2009·Application pending·0 cites
- 4447US2011130413A1Substituted quinazolinesSHIRE LLC·Filed 2009·Application pending·0 cites
- 4546US6258840B1Analogues or derivatives of quercetin (prodrugs)COBRA THERAPEUTICS LTD·Filed 1997·Granted Jul 10, 2001·8 cites·22 claims
- 4644US8530651B2Process for the preparation of anagrelide and analoguesGOLDING BERNARD·Filed 2009·Granted Sep 10, 2013·0 cites·7 claims
- 4744US2011086851A1Substituted quinazolines and their uses for myeoloprolific and thrombotic diseasesGOLDING BERNARD·Filed 2009·Application pending·0 cites
- 4844US2009326223A1Synthesis of 2-amino-substituted 4-oxo-4h-chromen-8.yl-trifluoro-methanesulfonic acid estersGRIFFIN ROGER JOHN·Filed 2007·Application pending·0 cites
- 4943US2011065796A1Prodrugs of guanfacineSHIRE LLC·Filed 2010·Application pending·0 cites
- 5043US2011098278A1Galantamine amino acid and peptide prodrugs and uses thereofSHIRE LLC·Filed 2010·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bernard Thomas Golding files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →